3 tips and tricks for practices looking to boost the bottom line.
Amer Karam, MD, discusses the role of secondary cytoreductive surgery in ovarian cancer and the need for careful patient selection, plus the results from 3 clinical trials and the key differences between these efforts.
An 18-day-old girl whose right cheek had become increasingly red and warm over 24 hours was directly admitted to an inpatient unit. She had firmness and pain to the affected area, fussiness, increased sleeping, and poor feeding, preferring the bottle to breastfeeding. What's the diagnosis?
With growing public endorsement of the potential benefits of marijuana, it is important for health care providers to effectively counsel patients regarding its effects on fertility and future offspring.
Discover key strategies OB-GYNs can use to protect pregnant women from severe COVID-19 risks and ensure healthier maternal outcomes.
Nearly half (45%) of all pregnancies in the United States from 2015 to 2019 were unintended.
Farah Amro, MD, shares her research at the 2025 ACOG ACSM on leaving the placenta in situ in select patients with placenta accreta spectrum.
Falling energy prices offset modest gains in other categories
Ethan Lowder, BA, and Alexander Nagrebetsky, MD, MSc, reported that nearly 80% of children fast longer than recommended before surgery.
Despite a painful history, equitable care is imperative
Learn about the intersection of mental health and contraception, with evidence-based guidance on contraceptive options for patients with psychiatric conditions.
This Consult discusses the management of pregnancies achieved with in vitro fertilization and provides recommendations based on the available evidence.
When helping patients in the hardest moments of their lives, it is important to have empathy for them—and for ourselves.
Amy Valent, DO, MCR, discusses how continuous glucose monitors and smart insulin delivery tools are reshaping individualized care for pregnant patients with diabetes.
Little evidence supports the routine use of activity restriction for preterm birth and other obstetric conditions, and some data indicate adverse impact on obstetric outcomes.
Discover effective counseling techniques and overcome barriers to empower adolescents in making informed decisions about contraception, fostering trust, confidentiality, and autonomy in reproductive health care.
This article presents a clinical algorithm and four cases to consider.
The pandemic has forced us to get more creative in managing patients’ needs, especially when it comes to contraception
Interventions before and after birth can reduce the rising maternal mortality ratio.
Anna Cabeca, DO, FACOG, discusses dehydroepiandrosterone and associated misunderstandings.
Sarah Lee, MD, MBA, discusses the use of checkpoint inhibitors in endometrial cancer, research regarding the association between MSI-H, dMMR, and TMB-H disease, and the importance of broad molecular testing to ensure all eligible patients are appropriately matched to immunotherapeutic options.
A panelist emphasizes that the OASIS 4 findings, with those of prior OASIS studies, strongly support the use of this drug class for managing vasomotor symptoms (VMS) in patients with breast cancer receiving endocrine therapy and highlights the need for future research in underserved populations such as men with breast cancer and those with metastatic disease.
This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.
Gynecologic providers should feel more comfortable proactively addressing the sexual well-being of their patients.